Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
MSPrecise
print preview
bookmark
share with colleague
General Information
Company
DioGenix Inc.
Description
Next-generation sequencing assay that measures DNA mutations found in rearranged immunoglobin genes in B cells isolated from cerebrospinal fluid (CSF)
Molecular Target
Mechanism of Action
Diagnostic
Latest Stage of Development
Pilot
Indication
Neurology, Diagnostic
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy